Bryan Reasons

(Mr. Bryan Reasons CPA)

Currently holds positions in Mallinckrodt Plc, Recro Pharma Inc and Aclaris Therapeutics Inc

Performance

Average Return

-12.5%

30 Days

8.2%

90 Days

15.1%

120 Days
Success Rate

50%

30 Days

68%

90 Days

82%

120 Days

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Mallinckrodt Plc March 18, 2019 -
Independent Director Recro Pharma Inc March 3, 2017 -
Independent Director Aclaris Therapeutics Inc April 20, 2018 -
Chief Financial Officer, Senior Vice President - Finance Amneal Pharmaceuticals Inc Dec. 12, 2012 - Jan. 1, 2018
Acting Chief Financial Officer, Vice President - Finance Amneal Pharmaceuticals Inc June 29, 2012 - Dec. 12, 2012
Bryan Reasons's trades of Recro Pharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-28 2023-08-28
B Purchase
62,500 +27.3%
0.40
USD 25,000 		62,500 +27.3% 0.40 USD 25,000
2020-12-07 2020-12-03
S Sale
5,400 -31.8%
0.17
USD 891 		5,400 -31.8% 0.17 USD 891
2019-06-07 2019-06-07
B Purchase
5,400 +42.9%
8.96
USD 48,383 		5,400 +42.9% 8.96 USD 48,383
// ... existing code ...